Hello Heart, a digital therapeutics company that focuses on heart health, raised $70 million in Series D funding. Growth equity firm Stripes led the round. Hello Heart said it will use the funding to further research and develop AI use cases for heart health. Its flagship product is a blood pressure monitor coupled with an app that has been cleared by the U.S. Food and Drug Administration. The company said it has doubled its employer client base in the last few months.
Centene to sell Magellan Rx, PANTHERx Rare for $2.8B Sidekick
Sidekick Health, a German-based digital therapeutics company, raised $55 million in Series B funding. The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellington Partners, Asabys Partners, Frumtak Ventures and a U.S. -based strategic investor that will be named later. The company received $20 million in a Series A funding round in 2020. It will use the funding to expand its chronic disease treatments across therapeutic areas beyond its focus in inflammatory and Crohn’s diseases, as well as COVID-19.
Bright Health Group vows to boost cash reserves
Curebase, a clinical trial tech company, announced it raised $40 million in Series B funding. The round was led by Industry Ventures with participation from Acrew Capital, World Innovation Lab, Positive Sum, Acrew Capital, GGV Capital, Bold Capital and Xfund. The round also included a strategic investment from pharma giant Gilead Sciences. The two companies have worked together to implement Curebase’s decentralized clinical trial platform into Gilead’s interventional trials. Curebase said it will use the funding to advance its technical capabilities.
Sweat-enabled wearables company brings on former Time CEO as board member
Somatus, a value-based kidney care company, acquired the strategic assets from Lumiata, a healthcare-specific AI platform. The terms of the deal were not disclosed. Lumiata’s analytics tech can predict high-cost claims and disease progression, Somatus said. Lumiata’s Acting CEO Jessica McCarthy, will join Somatus as senior vice president of growth analytics. In February, Somatus received $325 million in Series E funding to push the six-year-old company into ‘unicorn’ status.
Other funding rounds and deals:
• Healthmap Solutions, a kidney health mapping solutions provider, raised $35M in funding.
• Element5, an AI-powered workflow automation solution company for post-acute care, raised $30M in a Series B funding round.
• Imagene AI, an AI-based precision medicine platform for cancer treatment decisions, raised $21.5M in funding.
• Capable Health, a developer platform for building HIPAA-compliant healthcare apps, raised $6M in seed funding.
• Frame Fertility, a platform designed to help people take early action on health and wellness issues that can affect fertility, raised $2.8M in seed funding.
If there is a digital health funding or M&A deal that we missed from this past week here, please email us.
Digital Health Business & Technology’s data team contributed to this roundup.
